Michael Karin
NIH Rank #1037
- Program Leader
- R01 Holder
- Top 10% Funded
- Early Career
- Diverse Portfolio
Researcher identity and coverage
- Current affiliation
- Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
- NIH RePORTER identity
- Profile ID 1861927Search this ID in NIH RePORTER
- ORCID iD
- https://orcid.org/0000-0002-2758-6473Verified identifier for this researcher
- ScienceDex PI coverage
- FY2024 through FY2026Career claims are limited to the years shown.
FY2026 award categories
- Pharmacology
NIH Funding · FY2026
Linked Award Amount
$3.7M
Full award amounts, FY2026
Award Records
5
Records listing this PI
Award-Linked Rank
#1,037
By linked amount among FY2026 PIs
Earliest Year Loaded
2024
ScienceDex PI coverage
Award-linked funding history
Linked NIH award amounts and rank by fiscal year.
FY2026 award records by amount
NIH award records listing Michael Karin as a PI. Multi-PI records show the full award amount for context.
- 5P01CA281819-03P01Role of hypernutrition and metabolic stress in non-alcoholic steatohepatitis (NASH) driven hepatocellular carcinoma (HCC)$2.3Maward amount
- 5U01CA274295-05U01Regulation of PDAC metabolism and immunity by collagen and its cleavage products$1Maward amount
- 5R01CA285997-04R01Collagen fibers and fragments regulate pancreatic cancer metabolism and growth$809.9Kaward amount
- 5R01DK133448-06R01The NRF2-FBP1 crossregulatory loop and the control of healthy and diseased liver metabolism$747Kaward amount
- 5R37AI043477-30R37NF-kappaB and Mitochondrial Signals as Positive and Negative Regulators of Inflammation$741.2Kaward amount
- 5R01CA281784-04R01A new mouse model for studying the pathogenesis and immunobiology of intrahepatic cholangiocarcinoma and improving its immunotherapy$696Kaward amount
- 5R01ES036571-02R01Effects of early life Triclosan exposure through lactation on the gut-liver axis and its implications in the development of steatotic liver disease in adults$678.8Kaward amount
- 5R01DK120714-09R01Control of Lipogenesis and Hepatic Steatosis by Caspase-2$674.2Kaward amount
Award organizations
Organizations that administered FY2026 awards listing Michael Karin as a PI.
Coverage and award-record milestones
Computed from the fiscal years currently available in ScienceDex.
- 2024First NIH AwardSanford Burnham Prebys Medical Discovery Institute
- 2024$500K Cumulative Funding
- 2024$1M Cumulative Funding
- 2024$2M Cumulative Funding
- 2024$5M Cumulative Funding
- 2024Entered Top 50% NationallyRanked #1072
- 2024Entered Top 25% NationallyRanked #1072
- 2024Entered Top 10% NationallyRanked #1072
- 2025$10M Cumulative Funding
- 2025Entered Top 5% NationallyRanked #850
- 2025Multi-Institutional ResearchAwards at 2 institutions
- 2025R01 Grant Holder
- 2025Program/Center Grant Leader
Shared-award investigators
Other investigators listed on at least one of the same NIH award records as Michael Karin.
David Anderson Scott
Sanford Burnham Prebys Medical Discovery Institute
3
shared awards
Neil Kaplowitz
Sanford Burnham Prebys Medical Discovery Institute
3
shared awards
Pablo Tamayo
Sanford Burnham Prebys Medical Discovery Institute
3
shared awards
Randal J. Kaufman
Sanford Burnham Prebys Medical Discovery Institute
3
shared awards
Andrew M Lowy
University of California, San Diego
2
shared awards
Andrew M Lowy
Sanford Burnham Prebys Medical Discovery Institute
2
shared awards
David A. Brenner
Sanford Burnham Prebys Medical Discovery Institute
2
shared awards
David A. Brenner
University of California, San Diego
2
shared awards
Jun Hee Lee
Sanford Burnham Prebys Medical Discovery Institute
2
shared awards
Jun Hee Lee
University of California, San Diego
2
shared awards